A Study of Nivolumab, Ipilimumab, and Chemotherapy in Participants With Non-small Cell Lung Cancer

Clinical trial NCT05599685 · COMPLETED

Trial details

NCT number: NCT05599685
Sponsor: Bristol-Myers Squibb
Status: COMPLETED
Study type: OBSERVATIONAL

Carcinoma, Non-Small-Cell Lung

Start date: 2022-10-19
Primary completion: 2025-09-16
Enrollment: 302

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.